Literature DB >> 33860187

Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine.

Matthew W Johnson1.   

Abstract

This viewpoint identifies pitfalls in the study of psychedelic compounds, including those that pose challenges for the potential use of psychedelics as medicines. They are as follows: (1) Sloppiness regarding use of the term "consciousness". (2) Inappropriate introduction of religious/spiritual beliefs of investigators or clinicians. (3) Clinical boundaries and other ethical challenges associated with psychedelic treatments.
© 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 33860187      PMCID: PMC8033601          DOI: 10.1021/acsptsci.0c00198

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  9 in total

Review 1.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

Review 2.  Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.

Authors:  Franz X Vollenweider; Katrin H Preller
Journal:  Nat Rev Neurosci       Date:  2020-09-14       Impact factor: 34.870

Review 3.  Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Authors:  Matthew W Johnson; Peter S Hendricks; Frederick S Barrett; Roland R Griffiths
Journal:  Pharmacol Ther       Date:  2018-12-04       Impact factor: 12.310

4.  Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Authors:  Robin L Carhart-Harris; David Erritzoe; Tim Williams; James M Stone; Laurence J Reed; Alessandro Colasanti; Robin J Tyacke; Robert Leech; Andrea L Malizia; Kevin Murphy; Peter Hobden; John Evans; Amanda Feilding; Richard G Wise; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

5.  Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

Authors:  R L Carhart-Harris; R Leech; T M Williams; D Erritzoe; N Abbasi; T Bargiotas; P Hobden; D J Sharp; J Evans; A Feilding; R G Wise; D J Nutt
Journal:  Br J Psychiatry       Date:  2012-01-26       Impact factor: 9.319

6.  Restructuring consciousness -the psychedelic state in light of integrated information theory.

Authors:  Andrew R Gallimore
Journal:  Front Hum Neurosci       Date:  2015-06-12       Impact factor: 3.169

7.  Rejecting impulsivity as a psychological construct: A theoretical, empirical, and sociocultural argument.

Authors:  Justin C Strickland; Matthew W Johnson
Journal:  Psychol Rev       Date:  2020-09-24       Impact factor: 8.934

8.  Dimensions of consciousness and the psychedelic state.

Authors:  Tim Bayne; Olivia Carter
Journal:  Neurosci Conscious       Date:  2018-09-19

9.  The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain.

Authors:  Manoj K Doss; Darrick G May; Matthew W Johnson; John M Clifton; Sidnee L Hedrick; Thomas E Prisinzano; Roland R Griffiths; Frederick S Barrett
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  9 in total
  12 in total

Review 1.  Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.

Authors:  David B Yaden; Dylan Earp; Marianna Graziosi; Dara Friedman-Wheeler; Jason B Luoma; Matthew W Johnson
Journal:  Front Psychol       Date:  2022-05-23

Review 2.  N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Authors:  Edward James; Joachim Keppler; Thomas L Robertshaw; Ben Sessa
Journal:  Hum Psychopharmacol       Date:  2022-02-17       Impact factor: 2.130

3.  Moving Past Mysticism in Psychedelic Science.

Authors:  James W Sanders; Josjan Zijlmans
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-04

4.  Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Authors:  Roberta Murphy; Hannes Kettner; Rick Zeifman; Bruna Giribaldi; Laura Kartner; Jonny Martell; Tim Read; Ashleigh Murphy-Beiner; Michelle Baker-Jones; David Nutt; David Erritzoe; Rosalind Watts; Robin Carhart-Harris
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

5.  Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency.

Authors:  Brian A Pace; Neşe Devenot
Journal:  Front Psychol       Date:  2021-12-10

Review 6.  Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Authors:  Maxemiliano V Vargas; Retsina Meyer; Arabo A Avanes; Mark Rus; David E Olson
Journal:  Front Psychiatry       Date:  2021-10-04       Impact factor: 4.157

7.  Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.

Authors:  Drummond E-Wen McCulloch; Maria Zofia Grzywacz; Martin Korsbak Madsen; Peter Steen Jensen; Brice Ozenne; Sophia Armand; Gitte Moos Knudsen; Patrick MacDonald Fisher; Dea Siggaard Stenbæk
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

8.  The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.

Authors:  Max Wolff; Lea J Mertens; Marie Walter; Sören Enge; Ricarda Evens
Journal:  J Psychopharmacol       Date:  2022-03       Impact factor: 4.153

9.  Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model.

Authors:  William Brennan; Alexander B Belser
Journal:  Front Psychol       Date:  2022-06-02

Review 10.  Psychedelics and health behaviour change.

Authors:  Pedro J Teixeira; Matthew W Johnson; Christopher Timmermann; Rosalind Watts; David Erritzoe; Hannah Douglass; Hannes Kettner; Robin L Carhart-Harris
Journal:  J Psychopharmacol       Date:  2021-05-29       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.